Hilaris Conferences invite you to be a part of the Biomarkers 2019 conference in Paris, France on September 26-27, 2019 to discuss today’s most researchable topic, Biomarkers. It is the indicator that can be accurately measured as signal of normal biological functioning, pathogenic paths or a drug response to a therapeutic drug mediation. Biomarkers 2019conference will offer a single, comprehensive platform for all those who like to embrace the empire of the mind and Medical field. We welcome all scientists, doctors, clinicians, investors, customers, legal experts, funders, regulators and academicians focused on the basic development and applications of Biomarkers.
Biomarkers play a dynamic role in accepting the relationships between exposure to environmental chemicals, the development of chronic human diseases, and the identification of subgroups that are at increased risk for disease. Biomarker is the indicator that can be accurately measured as signal of normal biological functioning, pathogenic paths or a drug response to a therapeutic drug mediation. Biomarkers are usually in molecular form. Biomarkers take place in various body functions, including disease diagnosis and prognosis, prediction and calculation of treatment response, and safety estimation.
Neurological Biomarkers 